A federal judge has thrown out a jury award of more than $27 million for a Little Rock, Ark., woman who developed breast cancer after taking hormone replacement therapy.

In February, a federal jury in Little Rock sided with Donna Scroggin in her lawsuit against drug makers Wyeth and Upjohn, awarding her $2.75 million in compensatory damages and $27 million in punitive damages. Jurors concluded that Wyeth inadequately warned Scroggin that its drugs Premarin and Prempro carried an increased risk of breast cancer. The suit also involved Upjohn’s Provera, an estrogen-only drug.